雍禾医疗(02279)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02279 雍禾医疗

10.340

+0.120

+1.17%

最高--	最低--	成交量48.00万
今开--	昨收10.220	日振幅3.72%
总市值54.50亿	流通市值54.50亿	总股本5.27亿
成交额496.16万	换手率0.09%	流通股本5.27亿
市净率2.73	ROE--	每股收益0.34
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

Data provider: Ningxia XSRK Technology Limited

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"market":"HK","stockBase":{"symbol":"02279","market":"HK","secType":"STK","nameCN":"雍禾医疗","latestPrice":10.34,"timestamp":1656058087017,"preClose":10.22,"halted":0,"volume":480000,"delay":0,"change":0.12,"changeRate":0.011742,"floatShares":527080416,"shares":527080416,"eps":0.34457698,"lyrEps":0.344577,"pbRate":2.73,"psRate":2.14,"amount":4961560,"amplitude":0.037182,"volumeRatio":1.0538610832440434,"dividePrice":0.089264,"prevYearClose":15.94,"fiveDayClose":9.96,"twentyDayClose":10},"adData":{"groupTypeList":[],"userSplitList":[]},"requestUrl":"/m/hq/s/02279","defaultTab":"news","newsList":[{"id":"2245240701","title":"【券商聚焦】平证证券建议积极关注雍禾医疗(02279) 予目标价11港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2245240701","media":"凤凰网港股","top":-1,"share":"https://www.laohu8.com/m/news/2245240701?lang=zh_CN&edition=full","pubTime":"2022-06-21 15:58","pubTimestamp":1655798335,"startTime":"0","endTime":"0","summary":"平证证券发研报指，雍禾医疗是中国植发行业的开创者和领路人，是国内唯一拥有植发技术自主知识产权的植发机构。该行予雍禾医疗11港元目标价与9港元止损价。2020年我国植发服务市场规模为134亿元，到2030年有望突破750亿元。2021年，公司共服务植发患者58464人，同比增速达15%。公司目前已经在全国53个城市、地区开设了54家门店。2022年公司门店数量有望达到70家。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"source_url":"http://hknews.szfuit.com/newRssInfo/feed?original_id=83a1d9fd3ac7afb2782c31473f96c08d","is_publish_highlight":false},{"id":"2244120744","title":"植发机构频频赴港上市 四大头部连锁品牌集中度待提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2244120744","media":"证券时报·e公司","top":-1,"share":"https://www.laohu8.com/m/news/2244120744?lang=zh_CN&edition=full","pubTime":"2022-06-20 19:24","pubTimestamp":1655724240,"startTime":"0","endTime":"0","summary":"植发领域内行业龙头雍禾医疗去年12月登陆港股市场后，目前市值站稳54亿港元，同业大麦植发也启动上市之路，同样瞄准港股。机构指出，目前我国植发连锁机构市占率仅为24%，远低于独立民营植发机构的46%。由...","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://finance.eastmoney.com/a/202206202418584410.html","is_publish_highlight":false},{"id":"2244618491","title":"南向资金6月16日净买入雍禾医疗4.65万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2244618491","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2244618491?lang=zh_CN&edition=full","pubTime":"2022-06-17 09:31","pubTimestamp":1655429488,"startTime":"0","endTime":"0","summary":"6月16日, 南向资金增持雍禾医疗4.65万股，连续3日增持。截止当日收盘，港股通共持有雍禾医疗2205.75万股，占流通股4.18%。雍禾医疗近5个交易日下跌3.71%，港股通累计增持97.85万股；近20个交易日下跌9.74%，港股通累计增持204.00万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022061709363483234444&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022061709363483234444&s=b","is_publish_highlight":false},{"id":"2241174866","title":"港股异动 | 雍禾医疗(2279.HK)一度涨超8% 连续7日获北水加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2241174866","media":"金融界网站","top":-1,"share":"https://www.laohu8.com/m/news/2241174866?lang=zh_CN&edition=full","pubTime":"2022-06-08 15:32","pubTimestamp":1654673537,"startTime":"0","endTime":"0","summary":"格隆汇6月8日丨“植发第一股”雍禾医疗(2279.HK)尾盘一度涨超8%，现报11.26港元，总市值60亿港元。昨日，南向资金再度增持雍禾医疗1.40万股，录得连续7日增持。目前，港股通共持有雍禾医疗2112.00万股，占流通股4%。公司营业收入、医生数量、植发医疗机构数量以及植发患者人数这四项关键指标均位列中国植发行业第一。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://hk.jrj.com.cn/2022/06/08153236712331.shtml","is_publish_highlight":false},{"id":"2241534238","title":"南向资金6月7日净买入雍禾医疗1.40万股 连续7日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2241534238","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2241534238?lang=zh_CN&edition=full","pubTime":"2022-06-08 09:31","pubTimestamp":1654651872,"startTime":"0","endTime":"0","summary":"6月7日, 南向资金增持雍禾医疗1.40万股，连续7日增持。截止当日收盘，港股通共持有雍禾医疗2112.00万股，占流通股4.00%。雍禾医疗近5个交易日上涨1.54%，港股通累计增持15.95万股；近20个交易日上涨10.11%，港股通累计增持210.10万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202206080936308048a360&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202206080936308048a360&s=b","is_publish_highlight":false},{"id":"2241296078","title":"雍禾医疗(02279)建议委任韩志梅为执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2241296078","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2241296078?lang=zh_CN&edition=full","pubTime":"2022-06-07 19:38","pubTimestamp":1654601930,"startTime":"0","endTime":"0","summary":"雍禾医疗(02279)发布公告，自股东周年大会结束起生效：翟锋已提出辞任非执行董事...","market":"us","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_30.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_30.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://www.zhitongcaijing.com/content/detail/735061.html","is_publish_highlight":false},{"id":"2241670806","title":"南向资金6月2日净买入雍禾医疗7.45万股 连续5日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2241670806","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2241670806?lang=zh_CN&edition=full","pubTime":"2022-06-06 09:31","pubTimestamp":1654479082,"startTime":"0","endTime":"0","summary":"6月2日, 南向资金增持雍禾医疗7.45万股，连续5日增持。截止当日收盘，港股通共持有雍禾医疗2108.70万股，占流通股4.00%。雍禾医疗近5个交易日上涨4.00%，港股通累计增持27.35万股；近20个交易日上涨1.56%，港股通累计增持288.55万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022060609374184550dcd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022060609374184550dcd&s=b","is_publish_highlight":false},{"id":"2240460096","title":"南向资金5月31日净买入雍禾医疗4.55万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2240460096","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2240460096?lang=zh_CN&edition=full","pubTime":"2022-06-01 09:31","pubTimestamp":1654047099,"startTime":"0","endTime":"0","summary":"5月31日, 南向资金增持雍禾医疗4.55万股，连续3日增持。截止当日收盘，港股通共持有雍禾医疗2100.60万股，占流通股3.98%。雍禾医疗近5个交易日上涨4.51%，港股通累计增持13.45万股；近20个交易日下跌8.26%，港股通累计增持285.90万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202206010937158289a7c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202206010937158289a7c8&s=b","is_publish_highlight":false},{"id":"2239188663","title":"记者手记：植发企业要有真本事才能避免昙花一现","url":"https://stock-news.laohu8.com/highlight/detail?id=2239188663","media":"证券日报网","top":-1,"share":"https://www.laohu8.com/m/news/2239188663?lang=zh_CN&edition=full","pubTime":"2022-05-30 11:35","pubTimestamp":1653881700,"startTime":"0","endTime":"0","summary":"唐朝诗人白居易曾在《因沐感发》诗中感叹：“沐稀发苦落，一沐仍半秃。”不仅是古人，防脱发、保卫发际线已成为不少现代人的心“头”大事。痛点即卖点，随着消费升级，防脱市场规模在日渐扩大，成员也在不断更迭，防...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://finance.eastmoney.com/a/202205302396044835.html","is_publish_highlight":false},{"id":"2239008132","title":"雍禾医疗2021年业绩发布：“第二曲线”养固发业务快速增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2239008132","media":"中国网","top":-1,"share":"https://www.laohu8.com/m/news/2239008132?lang=zh_CN&edition=full","pubTime":"2022-05-30 10:21","pubTimestamp":1653877260,"startTime":"0","endTime":"0","summary":"报告期内，雍禾医疗实现营业收入人民币21.69亿元，同比增长32.4%；毛利为人民币15.80亿元，同比增长29.3%；经调整净利润为人民币1.81亿元，同比增长32.8%。其中，被誉为雍禾医疗业绩增长“第二曲线”的养固发业务快速增长备受关注。因此，雍禾仍将加速医疗机构网络拓展，建立新的雍禾植发医疗机构、独立的史云逊医学毛发中心以及综合的毛发医院，以获得植发业务和医疗养固业务更快速的增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina_symbol","url":"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/roll/2022-05-30/doc-imizirau5562198.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.extra-info, .source{#sourceStyle#;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/roll/2022-05-30/doc-imizirau5562198.shtml","is_publish_highlight":false},{"id":"2238753115","title":"雍禾，植发泡沫背后","url":"https://stock-news.laohu8.com/highlight/detail?id=2238753115","media":"市场资讯","top":-1,"share":"https://www.laohu8.com/m/news/2238753115?lang=zh_CN&edition=full","pubTime":"2022-05-26 10:05","pubTimestamp":1653530751,"startTime":"0","endTime":"0","summary":"几天后，3月24日，雍禾医疗发布了2021年的全年业绩公告，植发生意的泡沫，一点点被戳开了。上市当天，雍禾也达到了近90亿港元的市值，但如今它似乎被人戳破了泡沫。雍禾医疗交出了上市后的首份成绩单。雍禾植发的养固服务在上线一年后，登记患者为59112人，超过了同期的植发患者人数50694人。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022052610055881f0c48e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022052610055881f0c48e&s=b","is_publish_highlight":false},{"id":"2231401681","title":"财华洞察|业绩变脸，雍禾医疗如何“止秃”？","url":"https://stock-news.laohu8.com/highlight/detail?id=2231401681","media":"财华社","top":-1,"share":"https://www.laohu8.com/m/news/2231401681?lang=zh_CN&edition=full","pubTime":"2022-04-29 17:03","pubTimestamp":1651223018,"startTime":"0","endTime":"0","summary":"“芭比Q”了！号称“植发第一股”雍禾医疗（02279.HK），上市之后业绩秒变脸，股价更是跌破发行价，跌幅最大已超50%，遭遇戴维斯双杀。反观与雍禾医疗同期上市的圣诺医药－B（02257.HK）、百心安－B（02185.HK）这两家医药领域的新股，股价均录得不同程度上涨且并非跌破发行价。","market":"hk","thumbnail":"https://images.finet.hk/photoLib/title/202204_1/81e09c80-7fde-4573-82b6-dfc6de4bf417.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202204_1/81e09c80-7fde-4573-82b6-dfc6de4bf417.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://www.finet.hk/newscenter/news_content/626ba9ea53243c5cfa64a611","is_publish_highlight":false},{"id":"2230423529","title":"“诚”风破浪，雍禾医疗为什么能成为“植发第一股”？","url":"https://stock-news.laohu8.com/highlight/detail?id=2230423529","media":"中国质量新闻网","top":-1,"share":"https://www.laohu8.com/m/news/2230423529?lang=zh_CN&edition=full","pubTime":"2022-04-28 16:01","pubTimestamp":1651132905,"startTime":"0","endTime":"0","summary":"2022年3月，雍禾医疗在植发行业做了一件大事。2022年3月7日，雍禾医疗正式被纳入恒生综合指数成份股，同时接入港股通。自上市以来，雍禾医疗备受机构关注。2021年3月，雍禾医疗与中山大学达成战略合作，联合研发人体毛囊再生技术，被称为“全球植发行业的里程碑事件”。2022年3月，雍禾医疗首创“植发医生分级诊疗体系”，发布《植发医生分级诊疗体系白皮书》。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina_symbol","url":"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/jjxw/2022-04-28/doc-imcwiwst4527364.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.extra-info, .source{#sourceStyle#;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/jjxw/2022-04-28/doc-imcwiwst4527364.shtml","is_publish_highlight":false},{"id":"2230717298","title":"南向资金4月25日净买入雍禾医疗27.00万股 连续7日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2230717298","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2230717298?lang=zh_CN&edition=full","pubTime":"2022-04-26 09:31","pubTimestamp":1650936686,"startTime":"0","endTime":"0","summary":"4月25日, 南向资金增持雍禾医疗27.00万股，连续7日增持。截止当日收盘，港股通共持有雍禾医疗1814.70万股，占流通股3.44%。雍禾医疗近5个交易日下跌15.61%，港股通累计增持140.45万股；近20个交易日下跌12.22%，港股通累计增持919.70万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202204260938308040c4d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202204260938308040c4d0&s=b","is_publish_highlight":false},{"id":"2229534911","title":"南向资金4月21日净买入雍禾医疗16.45万股 连续5日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2229534911","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2229534911?lang=zh_CN&edition=full","pubTime":"2022-04-22 09:31","pubTimestamp":1650591072,"startTime":"0","endTime":"0","summary":"4月21日, 南向资金增持雍禾医疗16.45万股，连续5日增持。截止当日收盘，港股通共持有雍禾医疗1784.10万股，占流通股3.38%。雍禾医疗近5个交易日下跌10.63%，港股通累计增持174.40万股；近20个交易日下跌6.45%，港股通累计增持1538.95万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20220422093802804018d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20220422093802804018d8&s=b","is_publish_highlight":false},{"id":"2228697948","title":"南向资金4月19日净买入雍禾医疗20.75万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2228697948","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2228697948?lang=zh_CN&edition=full","pubTime":"2022-04-20 09:31","pubTimestamp":1650418271,"startTime":"0","endTime":"0","summary":"4月19日, 南向资金增持雍禾医疗20.75万股，连续3日增持。截止当日收盘，港股通共持有雍禾医疗1695.00万股，占流通股3.21%。雍禾医疗近5个交易日上涨0.31%，港股通累计增持83.30万股；近20个交易日上涨13.10%，港股通累计增持1524.20万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20220420093617803fb391&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20220420093617803fb391&s=b","is_publish_highlight":false},{"id":"2227014666","title":"雍禾医疗上市首秀，植发收入增幅下滑，客单价首降","url":"https://stock-news.laohu8.com/highlight/detail?id=2227014666","media":"中国科技新闻网","top":-1,"share":"https://www.laohu8.com/m/news/2227014666?lang=zh_CN&edition=full","pubTime":"2022-04-15 15:57","pubTimestamp":1650009420,"startTime":"0","endTime":"0","summary":"从财报数据来看，雍禾医疗在营收方面依旧保持着良好的增长势头，2021年营业收入为21.69亿元，同比增长32.37%，而净利润则下滑25.62%至1.21亿元，出现增收不增利的境况。值得注意的是，2021年，雍禾医疗的植发客单价出现自2018年以来的首次下降，仅为26643元，而此前两年的客单价分别为27799元和27868元。针对植发市场未来发展前景，以及雍禾医疗植发业务竞争优势等方面的问题，中国科技新闻网致电雍禾医疗并发送沟通函，对方客服人员表示会反映至相关部门。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022041516043379b05b76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022041516043379b05b76&s=b","is_publish_highlight":false},{"id":"2226963685","title":"港股雍禾医疗跌超15%，报10.82港元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2226963685","media":"媒体滚动","top":-1,"share":"https://www.laohu8.com/m/news/2226963685?lang=zh_CN&edition=full","pubTime":"2022-04-11 10:07","pubTimestamp":1649642829,"startTime":"0","endTime":"0","summary":"港股雍禾医疗跌超15%，报10.82港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina_symbol","url":"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/7x24/2022-04-11/doc-imcwiwst1125709.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.extra-info, .source{#sourceStyle#;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/7x24/2022-04-11/doc-imcwiwst1125709.shtml","is_publish_highlight":false},{"id":"2225900542","title":"“植发第一股”雍禾医疗上市后业绩降26% 销售及营销开支占收入一半","url":"https://stock-news.laohu8.com/highlight/detail?id=2225900542","media":"GPLP犀牛财经","top":-1,"share":"https://www.laohu8.com/m/news/2225900542?lang=zh_CN&edition=full","pubTime":"2022-04-08 14:20","pubTimestamp":1649398815,"startTime":"0","endTime":"0","summary":"2021年，雍禾医疗的核心业务植发医疗服务增长放缓。值得注意的是，2021年，雍禾医疗的销售及营销开支为10.72亿元，占总收入的一半，主要包括营销及推广开支、员工成本等；一般及行政开支为2.48亿元，主要包括员工成本、行政团队的经营相关开支等。2020年，雍禾医疗的销售及营销开支为7.80亿元，一般及行政开支为1.62亿元。加上所得税费用提升等综合作用的影响，雍禾医疗的纯利由2020年度的1.63亿元减少26.4%至2021年度的1.20亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202204081420287c8a70cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202204081420287c8a70cd&s=b","is_publish_highlight":false},{"id":"2225459810","title":"南向资金4月6日净买入雍禾医疗163.45万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2225459810","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2225459810?lang=zh_CN&edition=full","pubTime":"2022-04-07 09:31","pubTimestamp":1649295065,"startTime":"0","endTime":"0","summary":"4月6日, 南向资金增持雍禾医疗163.45万股，连续3日增持。截止当日收盘，港股通共持有雍禾医疗1589.50万股，占流通股3.01%。港股通增持金额前五个股分别为中国海洋石油、美团-W、快手-W、药明生物、紫金矿业。雍禾医疗近5个交易日上涨2.97%，港股通累计增持225.15万股；近20个交易日上涨14.17%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20220407093617803decfd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20220407093617803decfd&s=b","is_publish_highlight":false}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0382},{"period":"1month","weight":0},{"period":"3month","weight":-0.1311},{"period":"6month","weight":-0.3578},{"period":"1year","weight":-0.3456},{"period":"ytd","weight":-0.3513}],"websiteUrl":"http://www.yonghegroup.cn","compareEarnings":[{"period":"1week","weight":0.0306},{"period":"1month","weight":0.0767},{"period":"3month","weight":0.0147},{"period":"6month","weight":-0.0648},{"period":"1year","weight":-0.248},{"period":"ytd","weight":-0.0717}],"name":"雍禾医疗","description":"雍禾医疗集团有限公司是一家主要从事植发业务的中国公司。该公司的主营业务是通过医疗机构提供一站式毛发医疗服务，包括植发医疗、医疗养护、常规养护和其他配套服务。该公司还提供毛发修复产品和头皮清洁服务等。","exchange":"SEHK","nameEN":"YONGHE MEDICAL","compareStock":{"symbol":"HSI","name":"恒生指数"}},"isWeiXinMini":false,"pagemeta":{"title":"雍禾医疗(02279)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供雍禾医疗(02279)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"雍禾医疗,02279,雍禾医疗股票,雍禾医疗股票老虎,雍禾医疗股票老虎国际,雍禾医疗行情,雍禾医疗股票行情,雍禾医疗股价,雍禾医疗股市,雍禾医疗股票价格,雍禾医疗股票交易,雍禾医疗股票购买,雍禾医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情"}}